Back to top
more

Becton, Dickinson and Company (BDX)

(Real Time Quote from BATS)

$156.45 USD

156.45
200,920

-0.64 (-0.41%)

Updated Apr 9, 2026 11:06 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.93%
2Buy18.12%
3Hold10.10%
4Sell5.65%
5Strong Sell2.94%
S&P50011.36%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 244)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

Zacks Equity Research

Medical Product Q1 Earnings Due on May 2: BDX, DXCM & More

by Zacks Equity Research

The medical product sector shines bright at the moment owing to the prevalence of minimally invasive surgeries, liquid biopsy tests, and use of IT for ensuring quick and improved patient care among other things.

    Zacks Equity Research

    Is a Surprise Coming for Becton (BDX) This Earnings Season?

    by Zacks Equity Research

    Becton (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

      Zacks Equity Research

      Can CVS Health (CVS) Spring a Surprise this Earnings Season?

      by Zacks Equity Research

      CVS Health Corporation (CVS) is scheduled to report its first-quarter 2017 results before the opening bell on May 2.

        Zacks Equity Research

        Will LabCorp (LH) Pull a Surprise this Earnings Season?

        by Zacks Equity Research

        Laboratory Corp. of America Holdings (LH) or LabCorp is expected to report first-quarter 2017 results before the market opens on Apr 25.

          Zacks Equity Research

          Becton, Dickinson and Company (BDX) Up 3.8% Since Earnings Report: Can It Continue?

          by Zacks Equity Research

          Becton, Dickinson and Company (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

            Mark Vickery headshot

            Top Research Reports for March 3, 2017

            by Mark Vickery

            Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Caterpillar (CAT) and Broadcom (AVGO).

              Zacks Equity Research

              Becton, Dickinson Launches BD Resolve Early Access Program

              by Zacks Equity Research

              Leading global medical technology company, Becton, Dickinson and Company (BDX), popularly known as BD, recently announced an early access program for the BD Resolve Single-Cell Gene Expression platform.

                Zacks Equity Research

                Becton, Dickinson (BDX) Beats on Q1 Earnings & Revenues

                by Zacks Equity Research

                Becton, Dickinson and Company (BDX) reported first-quarter fiscal 2017 earnings of $2.33 per share, which beat the Zacks Consensus Estimate by 22 cents and increased from $1.96 posted in the year-ago quarter.

                  Zacks Equity Research

                  Becton, Dickinson (BDX) Beats Q1 Earnings & Revenues

                  by Zacks Equity Research

                  Becton, Dickinson???s adjusted earnings of $2.33 per share beat the Zacks Consensus Estimate by 22 cents.

                    Zacks Equity Research

                    Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?

                    by Zacks Equity Research

                    Becton, Dickinson and Company (BDX) is set to report first-quarter fiscal 2017 earnings results on Feb 2.